Identification of Barriers to Retinal Engraftment of Transplanted Stem Cells
Thomas V Johnson, Natalie D Bull, Keith R Martin
Investigative Ophthalmology & Visual Science | ASSOC RESEARCH VISION OPHTHALMOLOGY INC | Published : 2010
PURPOSE: Intraocular stem cell transplantation may be therapeutic for retinal neurodegenerative diseases such as glaucoma via neuronal replacement and/or neuroprotection. However, efficacy is hindered by extremely poor retinal graft integration. The purpose was to identify the major barrier to retinal integration of intravitreally transplanted stem cells, which was hypothesized to include the cellular and/or extracellular matrix (ECM) components of the inner limiting membrane (ILM). METHODS: Mesenchymal stem cells (MSCs) were cocultured on the vitreal surface of retinal explants. Retinal MSC migration was compared between control explants and explants in which portions of the ILM were remove..View full abstract
Awarded by Medical Research Council
Supported by the Glaucoma Research Foundation, the Richard Norden Glaucoma Research Fund, Fight for Sight, and an NC3Rs prize for reducing the use of animals in vision research. TVJ holds a Gates-Cambridge Scholarship and a National Institutes of Health Graduate Partnerships Program Fellowship. KRM holds a GlaxoSmithKline Clinician-Scientist Award.